ESR2 and colitis: ERβ has been linked to anti-inflammatory and colorectal cancer-protective effects, and we have previously demonstrated that deletion of ERβ in intestinal epithelial cells enhanced tumorigenesis and cytokine signaling in both sexes in the colitis-associated AOM/DSS mouse model15.